Advertisement
Singapore markets closed
  • Straits Times Index

    3,141.85
    +2.92 (+0.09%)
     
  • S&P 500

    5,069.76
    -8.42 (-0.17%)
     
  • Dow

    38,949.02
    -23.39 (-0.06%)
     
  • Nasdaq

    15,947.74
    -87.56 (-0.55%)
     
  • Bitcoin USD

    62,624.87
    +3,525.11 (+5.96%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,648.94
    +23.96 (+0.31%)
     
  • Gold

    2,037.80
    -4.90 (-0.24%)
     
  • Crude Oil

    78.30
    -0.24 (-0.31%)
     
  • 10-Yr Bond

    4.2740
    0.0000 (0.00%)
     
  • Nikkei

    39,166.19
    -41.84 (-0.11%)
     
  • Hang Seng

    16,511.44
    -25.41 (-0.15%)
     
  • FTSE Bursa Malaysia

    1,551.44
    +5.85 (+0.38%)
     
  • Jakarta Composite Index

    7,316.11
    -12.53 (-0.17%)
     
  • PSE Index

    6,944.71
    +68.19 (+0.99%)
     

Company News for Nov 16, 2023

  • Alcon Inc.’s (ALC) shares plummeted 5.9% after the company reported third-quarter 2023 adjusted earnings per share of $60.66, missing the Zacks Consensus Estimate of $0.67.

  • Shares of XPeng Inc. (XPEV) rose 2.3% after reporting third-quarter 2023 adjusted loss per share of $0.62, narrower-than the Zacks Consensus Estimate of a loss per share of $0.72.  

  • Olink Holding AB’s (OLK) shares surged 3.8% after posting third quarter 2023 adjusted loss per share of $0.01, narrower-than the Zacks Consensus Estimate of a loss per share of $0.08.  

  • Shares of Advance Auto Parts Inc. (AAP) tumbled 4.7% after the company reported third-quarter 2023 adjusted loss per share of $0.82, in contrast to the Zacks Consensus Estimate of an earnings per share of $1.42.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Alcon (ALC) : Free Stock Analysis Report

Advance Auto Parts, Inc. (AAP) : Free Stock Analysis Report

XPeng Inc. Sponsored ADR (XPEV) : Free Stock Analysis Report

Olink Holding AB (publ) Sponsored ADR (OLK) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research